What is Saama?
Founded in 1997 and headquartered in Campbell, California, Saama Technologies operates at the intersection of clinical research and advanced data analytics. The company's AI-driven platform is designed to integrate, curate, and animate diverse data sources, including structured, unstructured, and real-world data. This comprehensive approach enables Saama to deliver critical insights across all therapeutic areas, empowering pharmaceutical and biotechnology companies to streamline clinical trials and accelerate drug development. Saama's commitment to innovation positions it as a key player in the health tech sector, driving efficiency and data-driven decision-making.
How much funding has Saama raised?
Saama has raised a total of $507M across 4 funding rounds:
Series A
$35M
Private Equity
$40M
Debt
$2M
Other Financing Round
$430M
Series A (2015): $35M with participation from Carrick Capital Partners
Private Equity (2019): $40M led by Perceptive Advisors
Debt (2020): $2M supported by PPP
Other Financing Round (2021): $430M featuring Merck Global Health Innovation Fund, Northpond Ventures, and Amgen Business Development
Key Investors in Saama
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund is a growth investor that partners with innovative digital health and data science companies, focusing on facilitating and optimizing biopharmaceutical operations to improve patient care.
Perceptive Advisors
Perceptive Advisors is an investment firm focused on funding innovative healthcare and life sciences technologies, managing significant assets to support advancements in the sector.
Amgen Business Development
Amgen Oncology is dedicated to transforming cancer treatment through innovative therapies and a commitment to patient care, focusing on delivering high-quality biosimilar medicines and improving cancer outcomes.
What's next for Saama?
With its substantial funding history and recent strategic investment, Saama Technologies is poised for significant expansion. The company's focus on AI and advanced analytics in the clinical data space aligns with the growing demand for efficient and insightful research methodologies. Future developments are likely to center on further enhancing its platform's predictive capabilities, expanding its market reach, and forging new partnerships within the biopharmaceutical industry. The company's trajectory suggests a continued emphasis on leveraging data to expedite therapeutic advancements and improve patient outcomes.
See full Saama company page
